PTK2B and acute megakaryoblastic leukemia: Functional JAK3 mutations in the PTK (Pseudokinase) domains have been identified in acute megakaryoblastic leukemia (AMKL), T-cell prolymphocytic leukemia and NK T-cell lymphoma [15].